Praxis Precision Medicines attracts $110m

Cambridge, Massachusetts-based Praxis Precision Medicines, a biopharmaceutical company, has raised $110 million in Series C1 financing.

Cambridge, Massachusetts-based Praxis Precision Medicines, a biopharmaceutical company, has raised $110 million in Series C1 financing. Eventide Asset Management led the round from other investors that included Vida Ventures, Novo Holdings, Blackstone Life Sciences, OCV Partners, Avoro Capital Advisors, Surveyor Capital, Point72, Cormorant Asset Management, Qatar Investment Authority, Irving Investors, Adage Capital Management, Verition Fund Management and Ample Plus Fund.

Source: Press Release